Tramal, the drug produced by the "Grunenthal" firm (FRG) was used in the treatment of 478 patients with malignant neoplasms. In 24.46% patients, the side effects were noted, which were characteristic of the majority of analgetics and didn't threaten the life.
View Article and Find Full Text PDF